15.25
+0.33%
Close of 9 Nov 2026, in TWD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Healthconn
Its shares trade on Taipei Exchange under the ticker 6665.TWO. It has been listed since 23 November 2017. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.13bn and net income of TWD 8.4m. At that date it held total assets of TWD 1.49bn and shareholders' equity of TWD 926.0m.
Healthconn Corp. provides customized lifestyle optimization solutions for the four dimensions of nutrition, exercise, stress management and sound sleep. The company is headquartered in Taipei City, Taipei. The company went IPO on 2017-11-23. The firm is engaged in the provision of precisely prevent medical integration services, molecular biology testing programs and accurate diagnostic testing services. The precisely prevent medical integration services include precisely prevention, disease management and health promotion services. The molecular bioassay services include food safety testing and functional medical testing services. The accurate diagnostic testing services include molecular testing and clinical microbiological testing services, as well as the development and operation of medical health institutions. The firm is also engaged in the medical equipment sale business. The firm operates in the Taiwan market as well as in the mainland China market.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 23 Nov 2017
- Website
- healthconn.com ↗
Leadership
Pay as last reported
- Mr. Yingshi HuangChairman of the Board, Acting General Manager, since 2023
- Yayu ZouGeneral Manager, Director, since 2022
- Mr. Junlong LaiDeputy General Manager
- Ms. Xiaoying ZhangDeputy General Manager
- Peiyi LianHead of Finance
- Ruojing WangHead of Accounting
- Ruitai HongDirector
- Rui-Xia WanDirector
- Ganren CaiIndependent Director
- Mr. Shu-Hsing LiIndependent Director
- Mingzhe XieIndependent Director
- Ruxia FuAssistant General Manager, since 2022
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Healthconn Corp provides precise prevention medical integration services in Taiwan and mainland China.
- Healthconn Corp offers molecular biology testing programs for food safety and functional medical testing.
- Healthconn Corp develops and operates medical health institutions for accurate diagnostic testing services.
Weaknesses
- Healthconn Corp's business is limited to Taiwan and mainland China markets.
- Healthconn Corp's molecular bioassay services focus on food safety and functional medical testing.
- Healthconn Corp's medical equipment sale business is a secondary revenue stream.
Opportunities
- Healthconn Corp can expand its precise prevention medical integration services to new markets in Asia.
- Healthconn Corp can leverage its molecular biology testing programs for broader applications in healthcare.
- Healthconn Corp can grow its medical health institutions through strategic partnerships.
Threats
- Healthconn Corp faces competition from established healthcare providers in Taiwan and mainland China.
- Healthconn Corp's molecular bioassay services are vulnerable to regulatory changes in food safety standards.
- Healthconn Corp's medical equipment sale business is subject to market fluctuations in the healthcare sector.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.